Picture of Skinvisible logo

SKVI Skinvisible Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Skinvisible, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.7-1.45-1.07-1.22-2.38
Depreciation
Amortisation
Non-Cash Items0.7450.6640.6930.4841.31
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.790.7970.7360.7670.981
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.1280.0460.3750.045-0.077
Capital Expenditures-0.026-0.017-0.021-0.003-0.009
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0750
Sale of Fixed Assets
Cash from Investing Activities0.049-0.017-0.021-0.003-0.009
Net Issuance / Retirement of Debt
Cash from Financing Activities0.0780.006-0.324-0.0270.006
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.0010.0350.030.015-0.08